Mild cognitive impairment and dementia

被引:39
作者
Albert, Marilyn S. [1 ]
Blacker, Deborah [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21212 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
Alzheimer's disease; MCI; biomarkers; APOE; clinical trials;
D O I
10.1146/annurev.clinpsy.1.102803.144039
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Mild cognitive impairment (MCI) is a clinical syndrome thought to represent the transition between normal function and dementia. This review describes data that support the existence of such a transitional phase, outlines the heterogeneity of MCI and how that has influenced the evolving concept of MCI, and discusses the impact of heterogeneity on recent MCI clinical trials.
引用
收藏
页码:379 / 388
页数:10
相关论文
共 38 条
  • [1] Albert Marilyn S., 1996, P217
  • [2] Alzheimer A., 1907, ALLG Z PSYCHIAT, V64, P146, DOI DOI 10.1002/CA.980080612
  • [3] CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
    Andreasen, N
    Blennow, K
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (03) : 165 - 173
  • [4] [Anonymous], 1997, Neurobiol Aging, V18, pS1
  • [5] Bennett D. A., 2002, Neurology, V59, P198
  • [6] Bennett D. A., 2005, Neurology, V64, P834
  • [7] BLACKER D, 1994, RELIABILITY VALIDITY
  • [8] CSF biomarkers for mild cognitive impairment
    Blennow, K
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) : 224 - 234
  • [9] Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study
    Chan, D
    Janssen, JC
    Whitwell, JL
    Watt, HC
    Jenkins, R
    Frost, C
    Rossor, MN
    Fox, NC
    [J]. LANCET, 2003, 362 (9390) : 1121 - 1122
  • [10] Psychiatric symptomatology and prodromal Alzheimer's disease
    Copeland, MP
    Daly, E
    Hines, V
    Mastromauro, C
    Zaitchik, D
    Gunther, J
    Albert, M
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17 (01) : 1 - 8